Research Article

Study on the Intervention Effect of Qi Gong Wan Prescription on Patients with Phlegm-Dampness Syndrome of Polycystic Ovary Syndrome Based on Intestinal Flora

Table 1

Anthropometric and metabolic parameters of all participants.

CharacteristicsPCOS with phlegm-dampness group (n = 20)PCOS with nonphlegm-dampness group (n = 20)Control group (n = 20) value

Age (years)30.15 ± 3.5128.85 ± 3.4129.45 ± 3.61NS
BMI (kg/m2)32.23 ± 5.0622.0 ± 2.1722.49 ± 3.31<0.001<0.0011.0
Waist circumference (cm)88.8 ± 6.1673.5 ± 4.4571.25 ± 5.09<0.001<0.0010.183
Hip circumference (cm)99.9 ± 2.6596.5 ± 2.4695.75 ± 1.83<0.001<0.0010.315
WHR0.89 ± 0.040.76 ± 0.040.74 ± 0.04<0.001<0.0010.162
FPG (mmol/L)5.8 ± 0.55.39 ± 0.575.33 ± 0.450.0140.0050.711
FINS (uU/mL)22.66 ± 10.6611.68 ± 5.368.78 ± 4.720.006<0.0010.346
HOMA-IR5.94 ± 3.022.83 ± 1.452.08 ± 1.160.004<0.0010.355
FSH (mIU/mL)6.59 ± 1.276.93 ± 0.697.06 ± 0.77NS
LH (mIU/mL)10.77 ± 3.1512.97 ± 2.275.61 ± 1.040.409<0.001<0.001
LH: FSH ratio1.66 ± 0.491.89 ± 0.350.8 ± 0.180.558<0.001<0.001
Estradiol (pg/mL)43.2 ± 9.438.4 ± 8.3138.7 ± 8.46NS
Progesterone (ng/mL)0.46 ± 0.220.36 ± 0.210.46 ± 0.18NS
Prolactin (ng/mL)11.45 ± 6.6210.56 ± 5.6511.88 ± 5.2NS
Testosterone (ng/mL)0.74 ± 0.240.61 ± 0.260.4 ± 0.140.219<0.0010.017

Data are presented as mean ± SD. Abbreviations: PCOS, polycystic ovary syndrome; BMI, body mass index; WHR, waist-to-hip ratio; FPG, fasting plasma glucose; FINS, fasting plasma insulin; HOMA-IR, homeostasis model assessment of insulin resistance; FSH, follicular stimulating hormone; LH, luteinizing hormone; , PCOS with phlegm-dampness group vs. PCOS with nonphlegm-dampness group; , PCOS with phlegm-dampness group vs. control group; , PCOS with nonphlegm-dampness group vs. control group. NS: there was no significant difference among the three groups,  > 0.05; the difference was statistically significant,  < 0.05. There is a significant difference between the two groups (<0.05); difference is highly significant (<0.01).